Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo

被引:54
作者
Heringer-Walther, Silvia [2 ]
Eckert, Klaus [3 ]
Schumacher, Sarah-Mai [4 ]
Uharek, Lutz [5 ]
Wulf-Goldenberg, Annika [3 ]
Gembardt, Florian [1 ,6 ]
Fichtner, Iduna [3 ]
Schultheiss, Heinz-Peter [4 ]
Rodgers, Kathy [7 ]
Walther, Thomas [1 ,6 ]
机构
[1] Univ Hull, Hull York Med Sch, Ctr Biomed Res, Kingston Upon Hull HU6 7RX, N Humberside, England
[2] Univ Leipzig, Dept Gynaecol, Leipzig, Germany
[3] Max Delbruck Ctr, Berlin, Germany
[4] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany
[5] Charite Univ Med Berlin, Dept Haematol, Berlin, Germany
[6] Erasmus MC, Dept Pharmacol, Rotterdam, Netherlands
[7] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90089 USA
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 06期
关键词
angiotensin; CD34; hematopoietic stem cell; NITRIC-OXIDE SYNTHASE; RECOVERY; ACTIVATION; PEPTIDES;
D O I
10.3324/haematol.2008.000034
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Effects of angiotensin (Ang)-(1-7), an AngII metabolite, on bone marrow-derived hematopoietic cells were studied. We identified Ang-(1-7) to stimulate proliferation of human CD34(+) and mononuclear cells in vitro. Under ill vivo conditions, we monitored proliferation and differentiation of human cord blood mononuclear cells in NOD/SCID mice. Ang-(1-7) stimulated differentially human cells in bone marrow and accumulated them in the spleen. The number of HLA-I+ and CD34(+) cells in the bone marrow was increased 42-fold and 600-fold, respectively. These results indicate a decisive impact of Ang-(1-7) on hematopoiesis and its promising therapeutic potential in diseases requiring progenitor stimulation.
引用
收藏
页码:857 / 860
页数:4
相关论文
共 10 条
[1]
Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice [J].
Ellefson, DD ;
diZerega, GS ;
Espinoza, T ;
Roda, N ;
Maldonado, S ;
Rodgers, KE .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (01) :15-24
[2]
Angiotensin I, angiotensin II and their biologically active peptides [J].
Ferrario, CM .
JOURNAL OF HYPERTENSION, 2002, 20 (05) :805-807
[3]
Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy [J].
Rodgers, K ;
Xiong, SQ ;
diZerega, GS .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (02) :97-106
[4]
Effect of angiotensin II on hematopoietic progenitor cell proliferation [J].
Rodgers, KE ;
Xiong, S ;
Steer, R ;
diZerega, GS .
STEM CELLS, 2000, 18 (04) :287-294
[5]
Accelerated recovery from irradiation injury by angiotensin peptides [J].
Rodgers, KE ;
Xiong, SQ ;
diZerega, GS .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (05) :403-411
[6]
Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells [J].
Santhanam, Anantha Vijay R. ;
d'Uscio, Livius V. ;
Peterson, Timothy E. ;
Katusic, Zvonimir S. .
PEPTIDES, 2008, 29 (08) :1451-1455
[7]
Effects of angiotensin II skin wound healing receptor signaling during [J].
Takeda, H ;
Katagata, Y ;
Hozumi, Y ;
Kondo, S .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (05) :1653-1662
[8]
Unger T, 1996, J HYPERTENS, V14, pS95
[9]
Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia [J].
Urao, Norifumi ;
Okigaki, Mitsuhiko ;
Yamada, Hiroyuki ;
Aadachi, Yasushi ;
Matsuno, Kuniharu ;
Matsui, Akihiro ;
Matsunaga, Shinsaku ;
Tateishi, Kento ;
Nomura, Tetsuya ;
Takahashi, Tomosaburo ;
Tatsumi, Tetsuya ;
Matsubara, Hiroaki .
CIRCULATION RESEARCH, 2006, 98 (11) :1405-1413
[10]
Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells [J].
Zambidis, Elias T. ;
Park, Tea Soon ;
Yu, Wayne ;
Tam, Ada ;
Levine, Michal ;
Yuan, Xuan ;
Pryzhkova, Marina ;
Peault, Bruno .
BLOOD, 2008, 112 (09) :3601-3614